Inovio Pharmaceuticals, Inc. financial data

Symbol
INO on Nasdaq
Location
660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 266 % -35%
Debt-to-equity 69.4 % +72%
Return On Assets -93.4 % -20.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.1M shares +105%
Common Stock, Shares, Outstanding 36.7M shares +41.4%
Entity Public Float 208M USD +73.8%
Common Stock, Value, Issued 36.7K USD +41.4%
Weighted Average Number of Shares Outstanding, Basic 38.8M shares +42.8%
Weighted Average Number of Shares Outstanding, Diluted 38.8M shares +42.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 182K USD -69.2%
Research and Development Expense 62.2M USD -18.9%
General and Administrative Expense 33.8M USD -17.4%
Operating Income (Loss) -95.9M USD +24.9%
Net Income (Loss) Attributable to Parent -87.8M USD +27.9%
Earnings Per Share, Basic -2 USD/shares +49.5%
Earnings Per Share, Diluted -2 USD/shares +49.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.4M USD -29.2%
Cash, Cash Equivalents, and Short-term Investments 47.5M USD -57%
Accounts Receivable, after Allowance for Credit Loss, Current 840K USD -52.6%
Assets, Current 52.7M USD -55.2%
Property, Plant and Equipment, Net 3.09M USD -31.5%
Operating Lease, Right-of-Use Asset 7.36M USD -16.6%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 0 USD -100%
Other Assets, Noncurrent 2.01M USD +243%
Assets 68.2M USD -49%
Liabilities, Current 31.7M USD +20.1%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 8M USD -24.9%
Liabilities 39.7M USD +7.16%
Accumulated Other Comprehensive Income (Loss), Net of Tax -662K USD +4.03%
Retained Earnings (Accumulated Deficit) -1.77B USD -5.21%
Stockholders' Equity Attributable to Parent 28.5M USD -70.5%
Liabilities and Equity 68.2M USD -49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -26.9M USD +6.56%
Net Cash Provided by (Used in) Financing Activities 1.03M USD
Net Cash Provided by (Used in) Investing Activities -51.8K USD -100%
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 36.7M shares +41.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -25.9M USD -589%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.4M USD -29.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 349M USD +6.64%
Deferred Tax Assets, Gross 351M USD +6.51%
Operating Lease, Liability 10.7M USD -17.9%
Depreciation 371K USD -12.5%
Payments to Acquire Property, Plant, and Equipment 59.4K USD +66.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -87.7M USD +27.9%
Lessee, Operating Lease, Liability, to be Paid 12.8M USD -20.6%
Property, Plant and Equipment, Gross 20.1M USD -22%
Operating Lease, Liability, Current 2.66M USD +14.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.99M USD -15.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.59M USD +3.61%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.14M USD -31.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.32M USD -21.5%
Deferred Tax Assets, Operating Loss Carryforwards 250M USD +6.24%
Preferred Stock, Shares Issued 9 shares 0%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 24.6M USD +11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.13M USD -7.71%
Additional Paid in Capital 1.8B USD +1.09%
Preferred Stock, Shares Outstanding 9 shares 0%
Amortization of Intangible Assets 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 1.7M USD -14.5%
Interest Expense 1.09M USD -13.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%